You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Antibiotics for preventing recurrent sore throat
|
|---|---|
| Published in |
Cochrane database of systematic reviews, July 2015
|
| DOI | 10.1002/14651858.cd008911.pub2 |
| Pubmed ID | |
| Authors |
Gareth JY Ng, Stephanie Tan, Anh N Vu, Chris B Del Mar, Mieke L van Driel |
| Abstract |
Antibiotics are sometimes used to prevent recurrent sore throat, despite concern about resistance. However, there is conflicting primary evidence regarding their effectiveness. To assess the effects of antibiotics in patients with recurrent sore throat. The Cochrane Ear, Nose and Throat Disorders Group (CENTDG) Trials Search Co-ordinator searched the CENTDG Trials Register; Central Register of Controlled Trials (CENTRAL 2015, Issue 5); PubMed; EMBASE; CINAHL; Web of Science; Clinicaltrials.gov; ICTRP and additional sources for published and unpublished trials. The date of the search was 25 June 2015. Randomised controlled trials (RCTs) of antibiotics in adults and children suffering from pre-existing recurrent sore throat, defined as three or more sore throats in a year, examining the incidence of sore throat recurrence, with follow-up of at least 12 months post-antibiotic therapy. Two authors independently assessed trial quality and extracted data. Multiple attempts to contact the authors of one study yielded no response. We identified no trials that met the inclusion criteria for the review. We discarded the majority of the references retrieved from our search following screening of the title and abstract. We formally excluded four studies following review of the full-text report. There is insufficient evidence to determine the effectiveness of antibiotics for preventing recurrent sore throat. This finding must be balanced against the known adverse effects and cost of antibiotic therapy, when considering antibiotics for this purpose. There is a need for high quality RCTs that compare the effects of antibiotics versus placebo in adults and children with pre-existing recurrent sore throat on the following outcomes: incidence of sore throat recurrence, adverse effects, days off work and absence from school, and the incidence of complications. Future studies should be conducted and reported according to the CONSORT statement. |
X Demographics
The data shown below were collected from the profiles of 45 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 9 | 20% |
| United Kingdom | 8 | 18% |
| Canada | 1 | 2% |
| El Salvador | 1 | 2% |
| Japan | 1 | 2% |
| France | 1 | 2% |
| South Africa | 1 | 2% |
| Australia | 1 | 2% |
| Mexico | 1 | 2% |
| Other | 0 | 0% |
| Unknown | 21 | 47% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 35 | 78% |
| Practitioners (doctors, other healthcare professionals) | 7 | 16% |
| Scientists | 3 | 7% |
Mendeley readers
The data shown below were compiled from readership statistics for 146 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 146 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 22 | 15% |
| Student > Bachelor | 20 | 14% |
| Other | 11 | 8% |
| Researcher | 11 | 8% |
| Student > Postgraduate | 9 | 6% |
| Other | 25 | 17% |
| Unknown | 48 | 33% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 52 | 36% |
| Nursing and Health Professions | 13 | 9% |
| Psychology | 5 | 3% |
| Biochemistry, Genetics and Molecular Biology | 4 | 3% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 2% |
| Other | 14 | 10% |
| Unknown | 55 | 38% |
Attention Score in Context
This research output has an Altmetric Attention Score of 39. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 January 2023.
All research outputs
#1,062,162
of 25,714,183 outputs
Outputs from Cochrane database of systematic reviews
#2,111
of 13,134 outputs
Outputs of similar age
#12,660
of 277,085 outputs
Outputs of similar age from Cochrane database of systematic reviews
#43
of 282 outputs
Altmetric has tracked 25,714,183 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,134 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.8. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 277,085 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 282 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.